Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Sagent Pharmaceuticals Company Profile (NASDAQ:SGNT)

Consensus Ratings for Sagent Pharmaceuticals (NASDAQ:SGNT) (?)
Ratings Breakdown: 1 Sell Rating(s), 5 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $24.67 4.19% downside)

Analysts' Ratings History for Sagent Pharmaceuticals (NASDAQ:SGNT)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/25/2014S&P Equity ResearchDowngradeBuy -> Neutral$25.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
7/25/2014Bank of AmericaDowngradeBuy -> Neutral$25.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
5/15/2014Jefferies GroupReiterated RatingHold$23.00ViewTweet This Rating  Share This Rating on StockTwits
5/7/2014JPMorgan Chase & Co.Reiterated RatingHold$22.00 -> $24.00ViewTweet This Rating  Share This Rating on StockTwits
5/7/2014Jefferies GroupReiterated RatingHold$23.00ViewTweet This Rating  Share This Rating on StockTwits
4/29/2014Jefferies GroupReiterated RatingHold$23.00ViewTweet This Rating  Share This Rating on StockTwits
4/21/2014Jefferies GroupInitiated CoverageHold$23.00ViewTweet This Rating  Share This Rating on StockTwits
2/12/2014JPMorgan Chase & Co.Reiterated RatingNeutral$24.00 -> $22.00ViewTweet This Rating  Share This Rating on StockTwits
2/7/2014ZacksDowngradeOutperform -> Neutral$22.70ViewTweet This Rating  Share This Rating on StockTwits
2/7/2014Bank of AmericaUpgradeNeutral -> Buy$26.00 -> $25.00ViewTweet This Rating  Share This Rating on StockTwits
1/9/2014ZacksUpgradeNeutral -> Outperform$25.90ViewTweet This Rating  Share This Rating on StockTwits
1/6/2014RBC CapitalInitiated CoverageUnderperform$22.00ViewTweet This Rating  Share This Rating on StockTwits
10/8/2013ZacksDowngradeOutperform -> Neutral$25.90ViewTweet This Rating  Share This Rating on StockTwits
9/11/2013RBC CapitalUpgradeSector Perform -> Outperform$22.00 -> $25.00ViewTweet This Rating  Share This Rating on StockTwits
8/21/2013RBC CapitalBoost Price TargetSector Perform$19.00 -> $22.00ViewTweet This Rating  Share This Rating on StockTwits
8/7/2013JPMorgan Chase & Co.Boost Price Target$18.00 -> $21.00ViewTweet This Rating  Share This Rating on StockTwits
8/7/2013Jefferies GroupBoost Price TargetBuy$21.00 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
8/7/2013Needham & Company LLCBoost Price TargetBuy$20.00 -> $25.00ViewTweet This Rating  Share This Rating on StockTwits
7/18/2013ZacksUpgradeNeutral -> Outperform$24.70ViewTweet This Rating  Share This Rating on StockTwits
7/3/2013Bank of AmericaReiterated RatingNeutral$19.00 -> $22.00ViewTweet This Rating  Share This Rating on StockTwits
5/7/2013Jefferies GroupBoost Price TargetBuy$20.00 -> $21.00ViewTweet This Rating  Share This Rating on StockTwits
2/19/2013GuggenheimBoost Price TargetNeutral$17.00ViewTweet This Rating  Share This Rating on StockTwits
2/18/2013TheStreetUpgradeSell -> HoldViewTweet This Rating  Share This Rating on StockTwits
2/15/2013Piper JaffrayUpgradeNeutral -> Overweight$15.00 -> $22.00ViewTweet This Rating  Share This Rating on StockTwits
12/31/2012Morgan StanleyReiterated RatingEqual WeightViewTweet This Rating  Share This Rating on StockTwits
9/18/2012GuggenheimInitiated CoverageNeutral$16.00ViewTweet This Rating  Share This Rating on StockTwits
9/10/2012Needham & Company LLCReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
9/10/2012Jefferies GroupReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
8/13/2012Morgan StanleyDowngradeOverweight -> Equal WeightViewTweet This Rating  Share This Rating on StockTwits
8/10/2012RBC CapitalDowngradeOutperform -> Sector Perform$24.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
8/10/2012Needham & Company LLCLower Price TargetBuy$25.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2012 forward)